Adelfan-Ezidrex

Adelfan-esidrex: a drug for the treatment of arterial hypertension

Adelphan-esidrex is a combination drug containing three active ingredients: reserpine, dihydralazine and hydrochlorothiazide. The drug is manufactured in India by several companies, including Novartis, Sandoz Private Limited and Ciba-Geigy.

Adelfan-esidrex belongs to the pharmacological group of combinations of sympatholytics, vasodilators and diuretics. Reserpine is a sympatholytic, dihydralazine is a vasodilator, and hydrochlorothiazide is a diuretic.

The main indication for use of Adelfan-esidrex is arterial hypertension. The drug helps lower blood pressure, reduce the load on the cardiovascular system and prevent the development of complications associated with high blood pressure.

Despite its effectiveness, Adelfan-esidrex has a number of contraindications and side effects. The drug is not recommended for patients with depression, Parkinson's disease, epilepsy, peptic ulcer of the stomach and duodenum in the acute phase, as well as for pregnant women and children under 18 years of age.

Among the side effects that may occur when using Adelfan-Ezidrex are diarrhea, nausea, vomiting, dry mouth, swelling, headache, dizziness, depression, extrapyramidal disorders, changes in body weight and others.

In general, Adelfan-esidrex is an effective drug for the treatment of arterial hypertension, but its use should only be under medical supervision and in compliance with all recommendations and contraindications.